Applying mucosal barrier injury laboratory-confirmed bloodstream infection criteria in patients with solid tumors and hematologic malignancies: A retrospective cohort study looking for the real source of infection

Nenhuma Miniatura disponível
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
CAMBRIDGE UNIV PRESS
Citação
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, v.44, n.2, p.302-304, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
We evaluated the interference of the mucosal barrier injury (MBI) laboratory-confirmed bloodstream infection (MBI-LCBI) criteria on the central-line-associated bloodstream infection (CLABSI) incidence density, and the proportion of catheter-related bloodstream infections (CRBSIs) among those classified as MBI. We detected 339 CLABSIs: 15.0% were classified as MBI-LCBIs, and among these, 19.6% were classified as CRBSIs.
Palavras-chave
Referências
  1. ANVISA, 2007, INV CONTR BACK MULT
  2. Device-associates module, 2016, BLOODSTR INF EV CENT
  3. Epstein L, 2016, INFECT CONT HOSP EP, V37, P2, DOI 10.1017/ice.2015.245
  4. Islas-Munoz B, 2018, INT J INFECT DIS, V71, P59, DOI 10.1016/j.ijid.2018.03.022
  5. Kamboj M, 2014, INFECT CONT HOSP EP, V35, P99, DOI 10.1086/674406
  6. Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376
  7. Metzger KE, 2015, INFECT CONT HOSP EP, V36, P119, DOI 10.1017/ice.2014.38
  8. NCCN guidelines, PREVENTION TREATMENT
  9. See I, 2017, AM J INFECT CONTROL, V45, P321, DOI 10.1016/j.ajic.2016.10.015
  10. Vaughan AM, 2017, INFECT CONT HOSP EP, V38, P1385, DOI 10.1017/ice.2017.188